TRIALSITEIQ PUBLIC FEASIBILITY SCORECARD · GRADE B-

NCT06994806: A Study to Investigate the Safety and Efficacy of KQB168 as Monotherapy and in Combination in Participants With Advanced Solid Malignancies

Sponsor: Kumquat Biosciences Inc. · Phase: PHASE1 · Area: ONCOLOGY · Target Enrollment: 84 pts

Competing Trials Overlap

10 Active Trials

Excess Burn Exposure

$1,727,880

Rescue Site Savings

+$1,130,976

Unlock Full NCT06994806 Backup Super-Site Packet ($49 One-Time Pass)

Download the complete list of top-decile low-cannibalization clinical sites, verified Principal Investigator (PI) direct emails/phones, and protocol optimization benchmarks.

Download $49 NCT06994806 Rescue Dossier →